Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology


  1. 2010
  2. Published

    Combined Treatment with Dendritic Cell Vaccine and Low-Dose Cyclophosphamide in Patients with Malignant Melanoma

    Engell-Noerregaard, L., Ellebaek, E., Buch-Hansen, T. Z., Nikolajsen, K., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876-877 2 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. Published

    Dendritic Cells Transfected with mRNA for p53, Survivin and hTERT as Treatment for Patients With Malignant Melanoma or Breast Cancer-A Phase I Study

    Engell-Noerregaard, L., Hansen, T. H., Met, Ö., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 876 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  4. Published

    Increase of Circulating CD4(+)CD25(high)Foxp3(+) Regulatory T Cells in Patients With Metastatic Renal Cell Carcinoma During Treatment With Dendritic Cell Vaccination and Low-Dose Interleukin-2

    Berntsen, A., Brimnes, M. K., Straten, P. T., Svane, Inge Marie, Berntsen, A., Brimnes, M. K., Straten, P. T. & Svane, Inge Marie, 2010, In: Journal of Immunotherapy. 33, 4, p. 425-434 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2

    Berntsen, A., Brimnes, M. K., thor Straten, P. & Svane, Inge Marie, 2010, In: Journal of Immunotherapy. 33, 4, p. 425-34 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⿻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma

    Brimnes, M. K., Vangsted, Annette Juul, Knudsen, L. M., Gimsing, P., Gang, Uffe Jakob Ortved, Johnsen, H. & Svane, Inge Marie, 2010, In: Scandinavian Journal of Immunology. 72, 6, p. 540-7

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Therapeutic Vaccination Targeting Indoleamine-2, 3 Dioxygenase (IDO) Using a IDO Derived Class I Restricted Peptide in Combination with Aldara and Montanide for Patients With Locally Advanced or Metastatic Non Small-Cell Lung Cancer. A First-in-man Phase I Trial

    Buch-Hansen, T. Z., Sørensen, R. B., Mellemgaard, A., Straten, P. T., Andersen, Mads Hald, Svane, Inge Marie & Andersen, Mads Hald, 2010, In: Journal of Immunotherapy. 33, 8, p. 919-920 2 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  8. Published

    Therapeutic cancer vaccines

    Larsen, S. K., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 2010, In: Current Cancer Therapy Reviews. 6, 2, p. 163-174

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. 2009
  10. Published

    Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function

    Trepiakas, R., Pedersen, Anders Elm, Met, Özcan & Svane, Inge Marie, 2009, In: Vaccine. 27, 16, p. 2213-9 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53

    Sørensen, R. B., Andersen, R. S., Svane, Inge Marie, Engell-Noerregaard, L., Hadrup, S. R., Balslev, E., Andersen, Mads Hald & thor Straten, P., 2009, In: Clinical Cancer Research. 15, 5, p. 1543-9 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

    Andersen, Mads Hald, Sørensen, R. B., Brimnes, M. K., Svane, Inge Marie, Becker, J. C. & thor Straten, P., 2009, In: Journal of Clinical Investigation. 119, 8, p. 2245-56 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate

    Soleimani, A., Berntsen, A., Svane, Inge Marie & Pedersen, Anders Elm, 2009, In: Scandinavian Journal of Immunology. 70, 5, p. 481-9 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes

    Kloverpris, H., Karlsson, I., Bonde, J., Thorn, M., Vinner, L., Pedersen, A., Hentze, J., Andresen, B., Svane, I., Gerstoft, J., Kronborg, G., Fomsgaard, A., Kloverpris, H., Karlsson, I., Bonde, J., Thorn, M., Vinner, L., Pedersen, A. E., Hentze, J. L., Andresen, B. S. & 4 others, Svane, I. M., Gerstoft, J., Kronborg, Gitte & Fomsgaard, A., 2009, In: AIDS. 23, 11, p. 1329-40 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

    Engell-Noerregaard, L., Hansen, T. H., Andersen, Mads Hald, Thor Straten, P. & Svane, Inge Marie, 2009, In: Cancer Immunology, Immunotherapy. 58, 1, p. 1-14 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag)

    Wenandy, L., Kollgaard, T., Letsch, A., Andersen, R. S., Stather, D., Seremet, T., Svane, Inge Marie, Vindeløv, L., Andersen, M. H. & thor Straten, P., 2009, In: Leukemia. 23, 10, p. 1926-9 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase

    Sørensen, R. B., Berge-Hansen, L., Junker, N., Hansen, C. A., Hadrup, S. R., Schumacher, T. N. M., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2009, In: PLoS ONE. 4, 9, p. e6910

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines

    Sørensen, R. B., Junker, N., Kirkin, A., Voigt, H., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2009, In: Cancer Immunology, Immunotherapy. 58, 5, p. 665-75 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. 2008
  20. Published

    Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potential

    Met, Özcan, Eriksen, J. & Svane, Inge Marie, Oct 2008, In: Molecular Biotechnology. 40, 2, p. 151-60 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Cancer treatment: the combination of vaccination with other therapies

    Andersen, M. H., Sorensen, R. B., Schrama, D., Becker, J. C., Straten, P. T. & Svane, Inge Marie, 2008, In: Cancer Immunology, Immunotherapy. 57, 11, p. 1735-1743 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Characterization of a single peptide derived from cytochrome P4501B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patients

    Kvistborg, P., Hadrup, S. R., Andersen, M. H., Straten, P. T. & Svane, Inge Marie, 2008, In: Human Immunology. 69, 4-5, p. 266-272 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Immunogenicity of the hTERT540-548 peptide in cancer

    Wenandy, L., Sorensen, R. B., Sengelov, L., Straten, P. T., Andersen, M. H. & Svane, Inge Marie, 2008, In: Clinical Cancer Research. 14, 1, p. 4-7 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    RhoC a new target for therapeutic vaccination against metastatic cancer

    Wenandy, L., Sorensen, R. B., Straten, P. T., Andersen, M. H. & Svane, Inge Marie, 2008, In: Cancer Immunology, Immunotherapy. 57, 12, p. 1871-1878 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Studies on mRNA electroporation of immature and mature dendritic cells: Effects on their immunogenic potential

    Met, O., Eriksen, J. & Svane, Inge Marie, 2008, In: Journal of Molecular Microbiology and Biotechnology. 40, 2, p. 151-160 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. 2005
  27. Published

    Immunogenicity of Bcl-2 in patients with cancer

    Andersen, M. H., Svane, Inge Marie, Kvistborg, P., Nielsen, O. J., Balslev, E., Reker, S., Becker, J. C. & Straten, P. T., 15 Jan 2005, In: Blood. 105, 2, p. 728-34 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. 2003
  29. Published

    Clinical application of dendritic cells in cancer vaccination therapy

    Svane, Inge Marie, Soot, M. L., Buus, Søren & Johnsen, H. E., 2003, In: Acta Pathologica Microbiologica et Immunologica Scandinavica. 111, 7-8, p. 818-34 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 12 3 4 5 6 Next

ID: 4054758